Sign in
4

Changes in Ownership

Alaunos Therapeutics, Inc. Filed Acc 0001209191-18-000980

Director gave up 6,813 shares (to pay taxes)

  • Director acquired 17,258 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
BRENNAN MURRAY Director 2017-12-29 Grant or award +17,258 79,433 D
BRENNAN MURRAY Director 2017-12-30 Shares withheld for taxes −6,813 $4.14 $28,206 72,620 D
Loading xslF345X03/doc4.xml…